Kyle Fink

Kyle Fink

University of California, Davis

H-index: 22

North America-United States

About Kyle Fink

Kyle Fink, With an exceptional h-index of 22 and a recent h-index of 19 (since 2020), a distinguished researcher at University of California, Davis, specializes in the field of Neuroscience.

His recent articles reflect a diverse array of research interests and contributions to the field:

USE OF A SPLIT dCAS FUSION PROTEIN SYSTEM FOR EPIGENETIC EDITING

363 A CRISPR/dCas9 Epigenetic Therapuetic Approach for CASK-Related MICPCH

Biologics in brain repair.

Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model

Compositions and methods for editing of the cdkl5 gene

Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models of Cdkl5 deficiency

Polyamine metabolites as biomarkers in head and neck cancer biofluids

An in vivo cell-based delivery platform for zinc finger artificial transcription factors in pre-clinical animal models

Kyle Fink Information

University

Position

Assistant Professor Department of Neurology

Citations(all)

1871

Citations(since 2020)

1293

Cited By

1120

hIndex(all)

22

hIndex(since 2020)

19

i10Index(all)

28

i10Index(since 2020)

22

Email

University Profile Page

Google Scholar

Kyle Fink Skills & Research Interests

Neuroscience

Top articles of Kyle Fink

USE OF A SPLIT dCAS FUSION PROTEIN SYSTEM FOR EPIGENETIC EDITING

2024/4/18

363 A CRISPR/dCas9 Epigenetic Therapuetic Approach for CASK-Related MICPCH

Journal of Clinical and Translational Science

2024/4

Kyle Fink
Kyle Fink

H-Index: 17

Biologics in brain repair.

Brain Research Bulletin

2023/9/6

Kyle Fink
Kyle Fink

H-Index: 17

Julien Rossignol
Julien Rossignol

H-Index: 22

Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model

Molecular Therapy

2023/4/5

Compositions and methods for editing of the cdkl5 gene

2022/12/8

Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models of Cdkl5 deficiency

Human molecular genetics

2022/9/15

Polyamine metabolites as biomarkers in head and neck cancer biofluids

Diagnostics

2022/3/24

An in vivo cell-based delivery platform for zinc finger artificial transcription factors in pre-clinical animal models

Frontiers in Molecular Neuroscience

2022/1/27

Targeted epigenetic editing for X-linked intellectual disabilities

2022

Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells

Human molecular genetics

2021/6/15

Cell-Based Delivery Approaches for DNA-Binding Domains to the Central Nervous System

2021/12/12

Emerging gene and small molecule therapies for the neurodevelopmental disorder angelman syndrome

2021/7/1

A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies

Stem cells translational medicine

2021/7/1

Model of radiation-induced ambulatory dysfunction

Journal of Medical Sciences

2021/7/1

The iNs and outs of direct reprogramming to induced neurons

2020/9/4

Artificial escape from XCI by DNA methylation editing of the CDKL5 gene

Nucleic acids research

2020/3/18

Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome

Translational psychiatry

2020/1/27

See List of Professors in Kyle Fink University(University of California, Davis)